Authors: Kenji Yamamoto Virology Journal volume 19, Article number: 100 (2022) Abstract Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines […]
Authors: Jian Joli1, Patrizia Buck1, Stephan Zipfel1 and Andreas Stengel1,2* Frontiers in Psychiatry Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2. This systematic review was performed to describe symptoms, etiology, possible risk factors related to post-COVID-19 fatigue and the therapeutic approaches used for the treatment of post-COVID-19 fatigue. For the […]
Authors: Mihyun Choi 1, Min-Hwan Seo 1, Kwang-Eon Choi 2, Sukyeon Lee 1, Boyoon Choi 1, Cheolmin Yun 2, Seong-Woo Kim 1, Yong Yeon Kim 1 J Clin Med 2022 Jun 9;11(12):3318. doi: 10.3390/jcm11123318. Abstract A single-center retrospective observational case series was conducted. This case series enrolled patients who showed ophthalmic manifestations within one week after COVID-19 vaccination at Korea University Guro Hospital in Seoul, Korea, from May 2021 to January […]
Authors: Medically reviewed by Meredith Goodwin, MD, FAAFP — By S. Behring Health Line COVID-19 is normally associated with the lungs and respiratory system. Most people think of symptoms such as coughing and shortness of breath when they think of COVID-19. However, COVID-19 can impact the entire body and cause a wide range of symptoms and complications. Strokes, a […]
Authors: Michael Mörz Abstract: The current report presents the case of a 76-year-old man with Parkinson’s disease (PD)who died three weeks after receiving his third COVID-19 vaccination. The patient was first vac-cinated in May 2021 with the ChAdOx1 nCov-19 vector vaccine, followed by two doses of theBNT162b2 mRNA vaccine in July and December 2021. The […]
Authors: AJMC Staff Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™. Mount Sinai Study Finds COVID-19 Can Infect Eye Cells Although aerosol transmission is considered the primary cause of COVID-19 infection, findings from a study published this week by researchers at Mount Sinai indicates […]
Authors: Adan Salazar – https://www.infowars.com/posts/shock-doctor-warns-that-majority-of-vaccinated-patients-could-have-permanent-heart-damage-some-may-die-within-three-years/ Dr. Charles Hoffe found 62% percent of patients who received COVID mRNA jab test positive forblood clots…’The concern…is those people will probably all develop right-sided heart failure withinthree years and die because they now have increased vascular resistance through their lungs.A Canadian doctor demands further study into the link between […]
Authors: Lara Herrero, The Conversation Medical Xpress September 19, 2022 So you’ve had COVID and have now recovered. You don’t have ongoing symptoms and luckily, you don’t seem to have developed long COVID. But what impacts has COVID had on your overall immune system? It’s early days yet. But growing evidence suggests there are changes to […]
Authors: Nazeeh Hanna, MD1; Ari Heffes-Doon, MD1; Xinhua Lin, PhD2; et alClaudia Manzano DeMejia, MD2; Bishoy Botros, BS2; Ellen Gurzenda, BS2; Amrita Nayak, MD1 JAMA Pediatric Published online September 26, 2022. doi:10.1001/jamapediatrics.2022.3581 Vaccination is a cornerstone in fighting the COVID-19 pandemic. However, the initial messenger RNA (mRNA) vaccine clinical trials excluded several vulnerable groups, including young children and lactating individuals.1 The US Food and Drug Administration deferred the decision to authorize COVID-19 mRNA vaccines […]
Authors: Stephanie Seneff 1, Greg Nigh 2, Anthony M Kyriakopoulos 3, Peter A McCullough 4 PMID: 35436552 PMCID: PMC9012513 DOI: 10.1016/j.fct.2022.113008 Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide the mRNA from cellular […]
